Primary Outcomes
Description: Respiratory improvement is defined as sustained peripheral oxygen saturation (SpO2) ≥94% on room air.
Measure: Time from Randomization to Respiratory Improvement
Time: up to Day 28
Secondary Outcomes
Measure: Percentage of Participants Requiring Invasive Ventilation Time: up to Day 28
Measure: Percentage of Participants Requiring Supplemental Oxygen or Non-Invasive Ventilation in Participants who did not Require Supplemental Oxygen at Baseline Time: up to Day 28
Measure: Time from Randomization to Defervescence Time: up to Day 28
Measure: Time from Randomization to Respiratory Rate ≤ 24 Breaths per Minute on Room Air Time: up to Day 28
Measure: Time from Randomization to Cough Reported as Mild or Absent Time: up to Day 28
Measure: Time from Randomization to Dyspnea Reported as Mild or Absent Time: up to Day 28
Measure: Reduction of Immune Responses Time: up to Day 28
Measure: Reduction in Viral Load Time: up to Day 28
Measure: Duration of Hospitalization Time: up to Day 28
Measure: Number of Fatalities Time: up to Day 28
Measure: Number of Participants with Treatment-Emergent Adverse Events (TEAEs) Time: up to Day 28